GSK's two-drug HIV treatment meets main goal in late stage studies

(Reuters) – GlaxoSmithKline’s two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies, scoring key points in its rivalry with Gilead in the medical field.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *